Effectiveness of a Combined Strategy to Improve Therapeutic Compliance and Degree of Control Among Patients With Hypercholesterolaemia

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 358 participants.

Also called NCT02314663

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 358 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT02314663
Start date
(registry gives no type) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Not reported
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT02314663. Randomized; single masking; primary purpose treatment. Start 2013-01 (registry gives no type); primary completion 2015-12 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Effectiveness of a Combined Strategy to Improve Therapeutic Compliance and Degree of Control Among Patients With Hypercholesterolaemia
Acronym
EFESCOM
Condition
Hypercholesterolemia
Condition
Medication Adherence
Condition
Primary Health Care
Intervention (Device)
"COMBINED STRATEGY"
Lead sponsor
Gerencia de Atención Primaria, Albacete (class: other)
Collaborator
Instituto de Salud Carlos III (class: other government)

Record details

Record id
cardio:ct-nct02314663
Content hash
edc9088b836ae63c336984196b8c3720a33d534f5233a70be87ac6839a740ee2